|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-11-30
|
|
pubmed:abstractText |
Surgically created arteriovenous (AV) grafts are the most common type of hemodialysis vascular access in the United States, but fail frequently due to the development of venous stenosis. The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1740-7745
|
|
pubmed:author |
pubmed-author:BeckGerald JGJ,
pubmed-author:DAC Study Group,
pubmed-author:DemberLaura MLM,
pubmed-author:DepnerThomas ATA,
pubmed-author:DixonBradley SBS,
pubmed-author:FeldmanHarold IHI,
pubmed-author:GassmanJennifer JJJ,
pubmed-author:GreeneTomT,
pubmed-author:HimmelfarbJonathanJ,
pubmed-author:HunsickerLawrence GLG,
pubmed-author:KaufmanJames SJS,
pubmed-author:LawsonJeffrey HJH,
pubmed-author:MeyersCatherine MCM,
pubmed-author:MiddletonJohn PJP,
pubmed-author:RadevaMilenaM,
pubmed-author:SchwabSteve JSJ,
pubmed-author:WhitingJames FJF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
400-12
|
|
pubmed:dateRevised |
2009-10-5
|
|
pubmed:meshHeading |
pubmed-meshheading:16317809-Algorithms,
pubmed-meshheading:16317809-Arteriovenous Shunt, Surgical,
pubmed-meshheading:16317809-Aspirin,
pubmed-meshheading:16317809-Delayed-Action Preparations,
pubmed-meshheading:16317809-Dipyridamole,
pubmed-meshheading:16317809-Drug Combinations,
pubmed-meshheading:16317809-Graft Occlusion, Vascular,
pubmed-meshheading:16317809-Humans,
pubmed-meshheading:16317809-Platelet Aggregation Inhibitors,
pubmed-meshheading:16317809-Randomized Controlled Trials as Topic,
pubmed-meshheading:16317809-Renal Dialysis,
pubmed-meshheading:16317809-Research Design,
pubmed-meshheading:16317809-Sample Size,
pubmed-meshheading:16317809-Vascular Patency
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
|
|
pubmed:affiliation |
Nephrology Division, Veterans Affairs Medical Center and University of Iowa School of Medicine, Iowa City 52242-1081, USA. bradley-dixon@uiowa.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
